Quick Answer
Protagenic Therapeutics, Inc.new reported Total Assets of $1.96 million for fiscal year 2024.
Protagenic Therapeutics, Inc.new Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $1.96M | -54.8% |
| 2023 | $4.32M | -46.2% |
| 2022 | $8.04M | -27.3% |
| 2021 | $11.06M | +1157.9% |
| 2020 | $879.2K | +4.4% |
| 2019 | $842.3K | +20.9% |
| 2018 | $696.9K | -60.9% |
| 2017 | $1.78M | -43.7% |
| 2016 | $3.16M | +28278.3% |
| 2015 | $11.1K | -91.6% |
| 2015 | $133.0K | -45.9% |
| 2014 | $246.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $4.43M | +126.5% | -11.4% |
| September 30, 2025 | $5.00M | +231.7% | +5515.3% |
| March 31, 2025 | $89.1K | -96.5% | -95.4% |
| December 31, 2024 | $1.96M | -54.8% | +29.7% |
| September 30, 2024 | $1.51M | -72.2% | +2.8% |
| June 30, 2024 | $1.47M | -78.8% | -43.1% |
| March 31, 2024 | $2.58M | -66.4% | -40.4% |
| December 31, 2023 | $4.32M | -46.2% | -20.4% |
- Protagenic Therapeutics, Inc.new showed a decrease of -54.8% in Total Assets compared to the prior fiscal year.
- Over the 2014–2024 period, Protagenic Therapeutics, Inc.new’s total assets has grown by 695.1% (from $246.0 thousand to $1.96 million).
- The most recent figure is from Protagenic Therapeutics, Inc.new’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: